Quietmind Foundation

  • Quietmind Foundation
    • Services
    • Clinical Trials >
      • Light Therapy Single Subject Study
      • Intranasal PBM for Long-COVID
  • Quietmind Associates
    • Home Neurofeedback >
      • Research - IRB Review
    • Phototherapeutics & Neurofeedback >
      • Neurofeedback
      • Photobiomodulation (Light Therapy)
    • Equipment
  • Contact
  • BLOG


​Leading Edge Commentary

Interview on Neurofeedback as a Treatment for Neurodegenerative Disorders

10/30/2019

0 Comments

 
Linkedin reporter Zoe Peterkin wrote up some questions she submitted to me and the file linked below is the full article. I think it will be useful as a concise outlining of Quietmind Foundation's experience providing neuroteedback combined with photobiomodulation (light therapy) to stop and reverse dementia symptoms. Our recruiting has started to work such that we now need only 20 more subjects for our study. Pleaase call 610-940-0488 for details. 
impacts-of-neurofeedback-therapy-on-neurodegenerative-disorders.pdf
0 Comments

What is Photobiomodulation?

10/25/2019

0 Comments

 

Photobiomodulation
How light protects our memory​

Picture
Has your brain felt weak or foggy recently? Maybe it’s not functioning at the same speed that it used to. This decline in functioning may be a result of the health of the energy source in your brain cells, the mitochondria. At an early age we learn that the sun is responsible for all life on earth. Light plays a key role in our bodies processes, for example, our vision is based on photosensitive cells in our retinas called photoreceptors. It should come as no surprise then, that research now suggests that a specific kind of light from the sun can help heal illnesses, stopping, and even reversing dementia symptoms, e.g., memory loss and personality changes. 
​

Research has shown that stimulating your brain with near infrared light stimulates the action of our mitochondria and helps restore the brain to optimal functioning. This process is called Photobiomodulation (light therapy) and at Quietmind  infrared light or near-infrared (NIR) light to stimulate the mitochondria in our cells. Light therapy stimulates the mitochondria in our brain cells, or neurons.

Light therapy is being research as a treatment option ranging from replacing botox to memory loss prevention.


Light Therapy History

Photobiomodulation was first developed in the 1960s by Endre Mester of the Semmelweis University in Budapest, Hungary. Dr. Mester embarked on a study to assess if laser light (low infrared or near-infrared light) caused cancer in mice. He took some mice, divided them into two groups, shaved the fur off their backs, and applied laser treatment with a low powered ruby laser to one of the two groups. Laser did not cause cancer. In fact, it did quite the opposite. The mice exposed to the laser grew their fur back twice as fast as the untreated group. From this experiment onward, Dr. Mester has been dubbed the father of photobiomodulation. 
 In the early 2000s, Light Therapy was shown to improve the symptoms of neck pain, arthritis, and carpal tunnel syndrome beyond a placebo response, which led to the U.S. Food and Drug Administration's approval of the first low-level light therapy as medical devices for pain relief.

How Photobiomodulation / Light Therapy Works

Photobiomodulation - Light Therapy
Light exists on a spectrum. The human eye can only see a fraction of the existing natural light. Light therapy devices emit a low power near-infrared light (800nm - 1100nm) which is outside of the visible spectrum of human eyes but can still penetrate the human skin, skull, and brain. Infrared light is an essential component to Light Therapy because of its unique ability to both remedy chronic brain conditions and help maintain a healthy brain state. ​
If you think back to high school biology, you may remember the overworked phrase, “the mitochondria is the powerhouse of the cell.” Essentially, the mitochondria provides each cell with energy in the form of adenosine triphosphate (ATP) that maintains the cell and helps it to function properly. Our muscles flex and our heart beats all thanks to the diligent work of ATP.
Photobiomodulation - Light Therapy
Injury, disease, and/or old age can inflict stress upon our cells. Cell stress causes our mitochondria to act up and begin to produce something called nitric oxide. Nitric Oxide can often be useful for our bodies, helping us reduce muscle soreness and lowering our blood pressure. However, when produced in excess in the mitochondria, nitric oxide competitively stunts ATP production leading to something called oxidative stress. Oxidative stress has been known to cause a wide range of dreadful dysfunctions such as inflammation, cell death, high blood pressure, heart disease, cancer, and neurodegenerative conditions such as Alzheimer’s disease. 
The good news is that photobiomodulation eliminates these problems by disrupting the harmful effects that nitric oxide has on ATP production in the mitochondria. Specifically, light therapy targets a light sensitive enzyme called cytochrome c oxidase (CCO) in the mitochondria. The infrared or near infrared light absorbed by CCO helps increase the enzyme's activity and increases ATP production. Additionally, this process enhances nitric oxide synthesis, resulting in vasodilation (expansion of blood vessels) and increased cerebral perfusion (blood flow to the brain).

How does Light Therapy help memory loss?

Alzheimer’s Disease, dementia, or any neurodegenerative disorder, can be characterized by the progressive structural and functional loss and/or death of neurons which leads to a decline in cognitive, memory, and motor abilities. More specifically, reduced CCO activity (the enzyme we spoke about earlier in the mitochondria), lower ATP production, and disrupted connectivity within the default mode network (DMN) are hallmarks of neurodegenerative disease. 
Light therapy targets these exact problems and helps restore the brain to proper functioning. In most cases, Photobiomodulation shows beneficial effects by increasing mitochondrial function, reducing protein accumulation, reducing oxidative stress, and suppressing inflammation. In fact, many renowned studies have shown that PBM can specifically target these issues that are common to dementia and memory loss, leading to  improvements on the Mini Mental State Examination and Alzheimer's Disease Assessment Scale-cognitive subscale.

What does a light therapy session look like?

Since 2007, we have worked to understand how PBM and light therapy can improve memory loss in people with memory loss or dementia. ​There are a number of devices available for light therapy use. At QuietMind, we use the 1070nm pulsed (40h) Cognitolite, QM/Neuronic 1070nm transcranial PBM system and 810nm and the Vielight Neuro alpha (10hz) and gamma (40hz) pulse rates. ​
Picture
​ 
Cognitolite was developed in the UK and studied by researchers at Durham University’s Department of Neuronal Physics. Quietmind has been studying this device for 13 years. The Cognitolite uses 1068nm pulsed infrared LEDs that covers the whole head and shines light into the eyes. Cognitolite uses 1100

​

Picture

Vielight is a 4 diode headset with a single diode for intranasal NIR PBM stimulation. Its 5 powerful diodes are compared to the Cognitolite’s 1100 LEDs and also has a diode that is inserted into one nostril to stimulate the nasal blood vessels. QMF’s clinical research experience has convinced us that combining neurofeedback and infrared light therapy using the Cognitolite, QM/Neuronic or the Vielight, are worthwhile investments in healing and protecting our brain’s healthy functioning.


Light therapy can help with a wide range of issues outside of improving memory loss. For that reason, a light therapy session can look very different depending on what is being treated and what device is being used. Sessions can be administered in a clinical setting or at home.

The first step when using photobiomodulation to help with memory loss issues is to complete a baseline Quantitative EEG
brain mapping report to understand the extent of the current functioning. After the initial QEEG, an infrared transcranial headset is placed on the patient along with an intranasal neuro applicator. This combination allows the patient to receive light stimulation both on the top of their brain and the underside of the brain, as these pictures demonstrate. On average, the recommended treatment is around 20 minutes per day for up to a month.

Picture

Have you or someone you know experienced memory loss?

Quietmind Foundation is recruiting subjects who are interested in joining a clinical trials using the Cognitolite device at home for 2 months.  ​
Learn More
Call (610) 940-0488
0 Comments

Re-analysis of beta amyloid reducing drug shows promise in reversing dementia symptoms.

10/22/2019

0 Comments

 
The theory about how reducing beta amyloid plaque could positively effect dementia symptoms has now been shown to be true in a recent report on the drug ​aducanumab which is an antibody therapy. The medication is likely to be brought to market once approval is obtained and Biogen is going to apply for approval in early 2020. 

This drug study result supports what we already know about transcranial photobiomodulation (TPBM) with 1068nm pulsed infrared light stimulation. We also know that there are no adverse side effects with TPBM and the cost of treatment is almost certainly going to be significantly less than lifelong treatment with aducanumab.  
     Placebo                        Active
Treatment impact on amyloid plaque load
Quietmind Foundation has been providing integrative therapy that combines TPBM with home- based, brainwave biofeedback also called neurofeedback) training (NFB) that eliminates the underlying beta amyloid plaque while also increasing mitochondrial health and productivity with NFB to help repair our disrupted brain electrical networks independent of drug or other invasive procedures and unwanted side effects. QMF's longer-term therapy programs are conducted entirely at home by the patient and caregivers, with online training, clinical guidance, and periodic neuropsychiatric and neuropsychophsyiological evaluations at Quietmind Foundation's offices in Philadelphia, New York City, and Los Angeles. Please call Marvin Berman PhD at  610-940-0488 to be considered for one of our ongoing clinical trials or our longer-term comprehensive and individualized neurodegeneration treatment program.  ​
0 Comments

Excessive Brain Activity Shortens Life Span

10/18/2019

0 Comments

 
This article points at the fact that dysregulation of brain activity directly influences quality and lifespan itself. Overactivity is another way of describing dysregulated activity or in the parlance of neurotherapeutics, its inefficient brain activity. What we want as we age is to be more efficient in our movement and our thinking, this is what often is referred to as the 'wisdom of age'.  The work we do at QMF developing applications of digital neurotherapeutics(TM) is at its core, focused on enhancing neural efficiency and making sure we don't waste any of those little grey cells that Hercule Poirot depends on to solve the case. Our efforts are fixed on creating ways of noninvasively improving and maintaining optimal brain performance by maximizing neural efficiency.   

https://www.washingtonpost.com/science/2019/10/16/excessive-brain-activity-linked-shorter-life/
0 Comments

October 01st, 2019

10/1/2019

0 Comments

 
This paper suggests a novel and important aspect of the neurodegenerative process that needs to be better understood. We do know from studies at Durham University in the UK that 1065-1075nm light stimulation will enhance health and protect neurons from damage and thereby reduce the amount of fragments being created that may increase neural inflammation. Further research is needed to determine if the immune system is also enhanced in being able to remove these fragments more efficiently. Read about the study here: 
https://www.alzforum.org/news/research-news/mitochondrial-jetsam-spurs-neurodegeneration

Clinical trials at Quietmind Foundation using the 1065-1075nm pulsed infrared helmet are ongoing and people with diagnoses of early to mid-stage dementia are encouraged to contact Dr. Berman 610-940-0488 to discuss eligibility for the new home-based 60-day light therapy program. 


0 Comments

    QMF News

    Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general. 

    Archives

    June 2025
    March 2025
    January 2025
    December 2024
    October 2024
    July 2024
    March 2024
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    August 2022
    July 2022
    June 2022
    April 2022
    March 2022
    February 2022
    January 2022
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    April 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    April 2018
    March 2018
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    May 2017

    Categories

    All
    Alzheimer's
    Biofeedback
    Breathing Training
    Dementia
    Dementia Treatment
    Drug Free Anxiety Treatment
    Infrared Light
    Light Therapy
    Neurofeedback
    Neurotherapy
    Panic Disorder
    Photobiomodulation
    Relaxation
    TBI Treatment
    Therapy

    RSS Feed

Powered by Create your own unique website with customizable templates.
  • Quietmind Foundation
    • Services
    • Clinical Trials >
      • Light Therapy Single Subject Study
      • Intranasal PBM for Long-COVID
  • Quietmind Associates
    • Home Neurofeedback >
      • Research - IRB Review
    • Phototherapeutics & Neurofeedback >
      • Neurofeedback
      • Photobiomodulation (Light Therapy)
    • Equipment
  • Contact
  • BLOG